These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11928344)

  • 61. The psychological aspects of burning mouth syndrome.
    Kenchadze R; Iverieli M; Okribelashvili N; Geladze N; Khachapuridze N
    Georgian Med News; 2011 May; (194):24-8. PubMed ID: 21685517
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Utilization of Low-Dose Naltrexone for Burning Mouth Syndrome: A Case Report.
    Neuman DL; Chadwick AL
    A A Pract; 2021 May; 15(5):e01475. PubMed ID: 33999864
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contribution of neuroinflammation in burning mouth syndrome: indications from benzodiazepine use.
    Guarneri F; Guarneri C; Marini H
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S21-4. PubMed ID: 18837729
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome predictors of initial treatment with topical lubricant and parafunctional habit control in burning mouth syndrome (BMS).
    Ko JY; Park IH; Park HK; Kho HS
    Arch Gerontol Geriatr; 2011; 53(3):263-9. PubMed ID: 21075463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome.
    Treldal C; Jacobsen CB; Mogensen S; Rasmussen M; Jacobsen J; Petersen J; Lynge Pedersen AM; Andersen O
    Oral Dis; 2016 Mar; 22(2):123-31. PubMed ID: 26575180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic dilemma: the enigma of an oral burning sensation.
    Klasser GD; Epstein JB; Villines D
    J Can Dent Assoc; 2011; 77():b146. PubMed ID: 22260803
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
    Mahapatra SN; Hackett D
    Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vulvodynia: a psychophysiological profile based on electromyographic assessment.
    Jantos M
    Appl Psychophysiol Biofeedback; 2008 Mar; 33(1):29-38. PubMed ID: 18214669
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical profile of vulvodynia patients. A prospective study of 300 patients.
    Sadownik LA
    J Reprod Med; 2000 Aug; 45(8):679-84. PubMed ID: 10986689
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Atypical Lewy body disease revealed by burning mouth syndrome and a pseudo-psychiatric syndrome].
    Varvat J; Thomas-Anterion C; Decousus M; Perret-Liaudet A; Laurent B
    Rev Neurol (Paris); 2010 May; 166(5):547-9. PubMed ID: 20045161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Burning mouth syndrome: Clinical description, pathophysiological approach, and a new therapeutic option.
    Cárcamo Fonfría A; Gómez-Vicente L; Pedraza MI; Cuadrado-Pérez ML; Guerrero Peral AL; Porta-Etessam J
    Neurologia; 2017 May; 32(4):219-223. PubMed ID: 26778734
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Psychosocial profiles of patients with burning mouth syndrome.
    Carlson CR; Miller CS; Reid KI
    J Orofac Pain; 2000; 14(1):59-64. PubMed ID: 11203740
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Taste dysfunction in burning mouth syndrome.
    Grushka M; Sessle B
    Gerodontics; 1988 Oct; 4(5):256-8. PubMed ID: 3271722
    [No Abstract]   [Full Text] [Related]  

  • 74. Critical commentary 3: steroid dysregulation and stomatodynia (burning mouth syndrome).
    El-Etr M
    J Orofac Pain; 2009; 23(3):216-8; discussion 219-20. PubMed ID: 19639100
    [No Abstract]   [Full Text] [Related]  

  • 75. Psychology of Chronic Pelvic Pain: Prevalence, Neurobiological Vulnerabilities, and Treatment.
    Till SR; As-Sanie S; Schrepf A
    Clin Obstet Gynecol; 2019 Mar; 62(1):22-36. PubMed ID: 30383545
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sleep disturbance in patients with burning mouth syndrome: a case-control study.
    Adamo D; Schiavone V; Aria M; Leuci S; Ruoppo E; Dell'Aversana G; Mignogna MD
    J Orofac Pain; 2013; 27(4):304-13. PubMed ID: 24171180
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypnosis in Treatment of Stomatodynia:
    Maizeray S; Denis J; Piccoli GB; Chatrenet A; Maillard H
    Int J Clin Exp Hypn; 2021; 69(3):346-354. PubMed ID: 33955807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Capsaicin in burning mouth syndrome: titration strategies.
    Spice R; Hagen NA
    J Otolaryngol; 2004 Feb; 33(1):53-4. PubMed ID: 15291279
    [No Abstract]   [Full Text] [Related]  

  • 79. Real-world Discontinuation of Antidepressant Treatment in Patients with Burning Mouth Syndrome: A Chart Review.
    Watanabe M; Takenoshita M; Tu TTH; Toyofuku A
    Pain Med; 2020 Sep; 21(9):2009-2010. PubMed ID: 31841160
    [No Abstract]   [Full Text] [Related]  

  • 80. Optimal Dosage of Antidepressants in the Treatment of Burning Mouth Syndrome.
    Nagamine T
    Psychiatr Danub; 2022; 34(3):527-528. PubMed ID: 36256998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.